Progression‐free survival in oncological clinical studies: Assessment time bias and methods for its correction
Progression‐free survival (PFS) is a frequently used endpoint in oncological clinical studies. In case of PFS, potential events are progression and death. Progressions are usually observed delayed as they can be diagnosed not before the next study visit. For this reason potential bias of treatment e...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical statistics : the journal of the pharmaceutical industry 2021-07, Vol.20 (4), p.864-878 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!